Aleksi Tornio
aleksi.tornio@utu.fi +358 29 450 4608 +358 50 476 5715 Kiinamyllynkatu 10 Turku ORCID identifier: https://orcid.org/0000-0001-5713-5692 |
Areas of expertise
Clinical Pharmacology; Pharmacokinetics; Drug-drug interactions; Pharmacogenetics
Clinical Pharmacology; Pharmacokinetics; Drug-drug interactions; Pharmacogenetics
Publications
- A commonmissense variant of LILRB5 is associated with statin intolerance andmyalgia (2017)
- European Heart Journal
(A1 Refereed original research article in a scientific journal) - Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters (2017)
- Expert Opinion on Drug Metabolism and Toxicology
(A2 Refereed review article in a scientific journal ) - Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone (2016)
- Drug Metabolism and Disposition
(A1 Refereed original research article in a scientific journal) - High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population (2016)
- Basic and Clinical Pharmacology and Toxicology
(A1 Refereed original research article in a scientific journal) - Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans (2015)
- Clinical Pharmacology and Therapeutics
(A1 Refereed original research article in a scientific journal) - Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate Simvastatin (2015)
- Drug Metabolism and Disposition
(A1 Refereed original research article in a scientific journal) - Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril (2015)
- British Journal of Clinical Pharmacology
(A1 Refereed original research article in a scientific journal) - Effect of grapefruit juice on the bioactivation of prasugrel (2015)
- British Journal of Clinical Pharmacology
(A1 Refereed original research article in a scientific journal) - SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid (2015)
- Pharmacogenetics and Genomics
(A1 Refereed original research article in a scientific journal) - Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug-Drug Interactions (2014)
- Clinical Pharmacology and Therapeutics
(A1 Refereed original research article in a scientific journal) - Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel (2014)
- Clinical Pharmacology and Therapeutics
(A1 Refereed original research article in a scientific journal) - Gemfibrozil Impairs lmatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite (2013)
- Clinical Pharmacology and Therapeutics
(A1 Refereed original research article in a scientific journal) - Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects (2013)
- British Journal of Clinical Pharmacology
(A1 Refereed original research article in a scientific journal) - Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications (2012)
- Trends in Pharmacological Sciences
(A2 Refereed review article in a scientific journal ) - CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe (2009)
- Drug Metabolism and Disposition
(A1 Refereed original research article in a scientific journal) - The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: Evidence for mechanism-based inhibition of CYP2C8 in vivo (2008)
- Clinical Pharmacology and Therapeutics
(A1 Refereed original research article in a scientific journal) - Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone (2008)
- Drug Metabolism and Disposition
(A1 Refereed original research article in a scientific journal) - Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen (2007)
- European Journal of Clinical Pharmacology
(A1 Refereed original research article in a scientific journal) - Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide (2006)
- European Journal of Clinical Pharmacology
(A1 Refereed original research article in a scientific journal) - The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone (2006)
- European Journal of Clinical Pharmacology
(A1 Refereed original research article in a scientific journal)